Public ID: PID-9ZMOXG

Vaccine insurance eligibility evaluation tool approved in Czechia

in Czechia

Trade barrier summary

The Czech authorities have approved a health technology assessment (HTA) tool, which replaces the current legislative process to approve new antigens from 26 June 2025.

The HTA tool ensures that there is an approval process for all vaccines in Czechia and means that optional or non-routine vaccines will be reimbursed through public health insurance contributions made to a public health scheme. This new approach opens additional market opportunities for UK businesses, including innovative pharmaceutical companies, by offering a clearer and more efficient approval process.

---

Sectors affected

• Pharmaceuticals and biotechnology

---

Resolved

Yes - June 2025

---

Date reported

25 July 2024

---

Last updated

11 December 2025

---

Public ID

PID-9ZMOXG

---

If a trade barrier is affecting your exports or investment from the UK, please let us know on report a trade barrier .

If you export goods you can check duties and customs procedures for your chosen market.